Cite
Assessment of anti-nucleosome antibody (ANuA) isotypes for the diagnosis and prediction of systemic lupus erythematosus and lupus nephritis activity.
MLA
Zeng, Yanli, et al. “Assessment of Anti-Nucleosome Antibody (ANuA) Isotypes for the Diagnosis and Prediction of Systemic Lupus Erythematosus and Lupus Nephritis Activity.” Clinical & Experimental Medicine, vol. 23, no. 5, Sept. 2023, pp. 1677–89. EBSCOhost, https://doi.org/10.1007/s10238-022-00942-w.
APA
Zeng, Y., Xiao, Y., Zeng, F., Jiang, L., Yan, S., Wang, X., Lin, Q., Yu, L., Lu, X., Zhang, Y., & Lin, Y. (2023). Assessment of anti-nucleosome antibody (ANuA) isotypes for the diagnosis and prediction of systemic lupus erythematosus and lupus nephritis activity. Clinical & Experimental Medicine, 23(5), 1677–1689. https://doi.org/10.1007/s10238-022-00942-w
Chicago
Zeng, Yanli, Yun Xiao, Fanxiang Zeng, Longcan Jiang, Shuidi Yan, Xuelian Wang, Qiaoduan Lin, et al. 2023. “Assessment of Anti-Nucleosome Antibody (ANuA) Isotypes for the Diagnosis and Prediction of Systemic Lupus Erythematosus and Lupus Nephritis Activity.” Clinical & Experimental Medicine 23 (5): 1677–89. doi:10.1007/s10238-022-00942-w.